The chemotactic cytokine interleukin-8 - A cyst fluid marker for malignant epithelial ovarian cancer?

Gynecologic Oncology

Volumn 71, Issue 3, 1998, Pages 420-423

  Ivarsson, Karin ^a   Runesson, Eva ^a   Sundfeldt, Karin ^a   Haeger, Magnus ^a   Hedin, Lars ^a   Janson, Per Olof ^a   Brännström, Mats ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cancer; Cyst fluid; Cytokine; IL 8; Ovary

Indexed keywords

BIOCHEMICAL MARKER; CA 125 ANTIGEN; CHEMOKINE; INTERLEUKIN 8; TUMOR MARKER;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CYST FLUID; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN TISSUE; OVARY CANCER; OVARY CYST; PRIORITY JOURNAL;

EID: 0032409134     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1998.5198     Document Type: Article

References (23)

1. 1. Dietl J, Marzusch K: Ovarian surface epithelium and human ovarian cancer. Gynecol Obstet Invest 35:129-135, 1993
2. 2. Colombo MP, Modesti A, Parmiani G, Forni G: Local cytokine availability elicits tumor granulocute-T-lymphocyte cross talk. Cancer Res 52: 4853-4857, 1992
3. 3. Pekarek LA, Starr BA, Toledano AY, Schreiber H: Inhibition of tumor growth by elimination of granulocytes. J Exp Med 181:435-440, 1995
4. 4. Malik STA, Naylor MS, Balkwill FR: Cytokines and Ovarian Cancer, in Sharp F, Mason WP, Creasmon W, (eds.), Ovarian Cancer 2: Biology, Diagnosis and Management London, Chapman & Hall, 1992, pp 87-92
5. 5. Runesson E, Boström E, Janson PO, Brännström M: The human preovulatory follicle is a source of the chemotactic cytokine interleukin-8. Mol Hum Reprod 2:245-250, 1996
6. 6. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, Elner SG, Strieter RM: Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258:1798-1801, 1992
7. 7. Wang J, Huang M, Lee P, Komanduri K, Sharma S, Chen G, Dubinett SM: Interleukin-8 inhibits non-small cell lung cancer proliferation: a possible role for regulation of tumor growth by autocrine and paracrine pathways. J Interferon Cytokine Res 16:53-60, 1996
8. 8. Schadendorf D, Möller A, Algermissen B, Worm M, Sticherling M, Czarnetzki BM: IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J Immunol 151:2667-2675, 1993
9. 9. Punnonen J, Heinonen PK, Kuoppala T, Jansen CT, Punnonen R: Production of interleukin-1b and tumour necrosis factor-a in patients with benign or malignant ovarian tumors. J Cancer Res Clin Oncol 117:587-592, 1991
10. 10. Moradi MM, Carson LF, Weinberg JB, Haney AF, Twiggs LB, Ramakrishnan S: Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer. Cancer 72:2433-2438, 1993
11. 11. Gotlieb WH, Abrams JS, Watson JM, Velu TJ, Berek JS, Martinez-Maza O: Presence of interleukin 10 (IL-10) in the ascites of patients with ovarian and other intra-abdominal cancers. Cytokine 4:385-390, 1992
12. 12. Haeger M, Swahn M, Hahlin M, Horvath G, Bengtsson A: Increased concentrations of neopterin in plasma, ascites and cyst fluid in malignant ovarian tumours compared with benign ovarian tumours. Anticancer Res 16:3189-3192, 1996
13. 13. Karasik A, Mensczer J, Pariente C, Kanety H: Insulin-like growth factor-I (IGF-I) and IGF-binding protein 2 are increased in cyst fluids of epithelial ovarian cancer. J Clin Endocrin Metab 78:271-276, 1994
14. 14. Xu F-J, Ramakrishnan S, Daly L, Soper JT, Berchuck A, Clarke-Pearson D, Bast RC: Increased serum levels of macrophage colony-stimulating factor in ovarian cancer. Am J Obstet Gynecol 165:1356-1362, 1991
15. 15. Sylvester I, Yoshimura T, Sticherling M, Schröder J-M, Ceska M, Peichl P, Leonard EJ: Neotrophil attractant protein-1-immunoglobulin G immune complexes and free antiNAP-1 antibody in normal serum. J Clin Invest 90:471-481, 1992
16. 16. Neote K, Darbonne W, Ogez J, Horuk R, Schall TJ: Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells. J Biol Chem 268:12245-12249, 1993
17. 17. Harlozinska A, Bar JK, Gawlikowski W, Richter R, Cislo M: CA 125 and carcinoembryonic antigen levels in cyst fluid, ascites and serum of patients with ovarian neoplasms. Ann Chir Gynaecol 80:368-375, 1991
18. 18. Menczer J, Ben-Baruch G, Moran O, Lipitz S: Cyst fluid CA 125 levels in ovarian epithelial neoplasms. Obstet Gynecol 81:25-28, 1993
19. 19. Vercellini P, Oldani S, Felicetta I, Bramante T, Rognoni MT, Crosignani PG: The value of cyst puncture in the differential diagnosis of benign ovarian tumours. Hum Reprod 10:1465-1469, 1995
20. 20. Fleuren GF, Nap M, Aalders JG, Trimbos JB, de Bruijn HWA: Explanation of the limited correlation between tumor CA 125 content and serum CA 125 antigen levels in patients with ovarian tumours. Cancer 60:2437-2442, 1987
21. 21. Hirose K, Hakozaki M, Nyunoya Y, Kobayashi Y, Matsushita K, Takenouchi T, Mikata A, Mukaida N, Matsushima K: Chemokine gene transfection into tumour cells reduced tumorigenicity in nude mice in association with neutrophilic infiltration. Br J Cancer 72:708-714, 1995
22. 22. Smith DR, Polverini PJ, Kunkel SL, Orringer MO, Whyte RI, Burdick MD, Wilke CA, Strieter RM: Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma. J Exp Med 179:1409-1415, 1994
23. 23. Arenberg DA, Kunkel SL, Polverini PJ, Glass M, Burdick MD, Strieter RM: Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J Clin Invest 97:2792-2802, 1996